Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_assertion type Assertion NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_head.
- NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_assertion description "[CYP2C19 genetic polymorphism also affects the therapeutic outcome of gastroesophageal reflux disease (GERD), reflux oesophagitis and duodenal ulcers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_provenance.
- NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_assertion evidence source_evidence_literature NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_provenance.
- NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_assertion SIO_000772 18765869 NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_provenance.
- NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_assertion wasDerivedFrom befree-20140225 NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_provenance.
- NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_assertion wasGeneratedBy ECO_0000203 NP490503.RA4c8T9xFOhVyKJOFusQc0o_Vo5Z1Q-qJwRC-yybwLiVo130_provenance.